Get started
Author

Peihua Lu

Observed name: Pei-Hua Lu
ORCID: 0009-0005-2855-8780
Observed ORCID: 0009-0005-2855-8780
OpenAlex ID: A5100559279
[Chondroitin sulfate proteoglycans in neural development and regeneration].
2007 · Wen-Li Gu, Pei-Hua Lu · PubMed · 255
Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial
2022 · Peihua Lu, Ying Liu, et al. · Blood · 158
PDF
CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory/Relapsed Peripheral T-Cell Lymphoma: Phase I Clinical Trial
2024 · Junfang Yang, Xian Zhang, et al. · Blood · 8
PDF
Analysis of 53 Patients with Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) Treated with CD7-Targeted CAR-T Cell Therapy
2022 · Xian Zhang, Junfang Yang, et al. · Blood · 7
Persistence of MHC DR Nonexpression on Swine Cells by Introduction of a Mutated MHC Class II Transactivator Gene: A Comparison with the Effect Induced by Antisense RNA
2004 · Qishui Ou, Lin Lin, et al. · Journal of Clinical Immunology · 5
Correction: Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
2024 · Lan-Ping Xu, Pei-Hua Lu, et al. · Bone Marrow Transplantation · 3
PDF
CTD402, allogeneic anti-CD7 CAR t-cell, in relapsed or refractory (R/R) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) - report of clinical outcomes at the recommended phase 2 dose (RP2D)
2025 · Peihua Lu, Yong-xian Hu, et al. · Blood · 2
PDF
A Novel Full-Spectral Flow Cytometric Assay for Detection of Measurable Residual Disease in Patients with B-Lymphoblastic Leukemia
2024 · Ke Li, Man Chen, et al. · Blood · 2
PDF
CD7-targeted CAR-T cell therapy showed a high efficacy for 30 patients with relapsed or refractory central nervous system T-cell lymphoblastic leukemia/lymphoma
2025 · Junfang Yang, Xian Zhang, et al. · Blood · 1
Safety and efficacy of IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) in the treatment of primary/secondary central nervous system lymphoma
2025 · Wenjun Zhang, Xiyang Liu, et al. · Blood · 1
PDF
Safety and efficacy of CD19/CD22/CD20 multi-targeted CAR-T therapy in patients with refractory/relapsed B-cell non-Hodgkin lymphoma
2025 · Xiyang Liu, Liqing Kang, et al. · Blood · 1
PDF
Clinical efficacy of allogeneic hematopoietic stem cell transplantation in infant acute leukemia
2025 · Ruijuan Sun, Min Xiong, et al. · Blood
PDF
Glofitamab use may significantly reduce the efficacy of CAR-T therapy in R/R DLBCL patients
2025 · Xiyang Liu, Hongjia Zhu, et al. · Blood
PDF
Efficacy and safety analysis of letermovir for the prevention of CMV infection after haploidentical hematopoietic stem cell transplantation in children with acute leukemia
2025 · Huili Zhu, Zhijie Wei, et al. · Blood
PDF
Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis
2025 · Xingyu Cao, Yue Lu, et al. · Blood
PDF
Autologous hematopoietic stem cell transplantation followed by CD19/CD22 dual-target CAR-T therapy for refractory or relapsed burkitt lymphoma
2025 · Xian Zhang, Lin Wang, et al. · Blood
A novel loop-structured CD19/CD22 dual-targeting CAR-T therapy for patients with refractory/relapsed B-cell non-Hodgkin lymphoma
2025 · Wei Zhang, Nan Xu, et al. · Blood
PDF
Relapsed/Refractory AML1::ETO Acute Myeloid Leukemia Was Successfully Treated By Allogeneic Hematopoietic Stem Cell Transplantation with Modifyed Myeloablative Preconditioning Contains Olaparib
2024 · Song Xue, Peihua Lu, et al. · Blood
PDF
Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study
2024 · Yun Wang, Ruijuan Sun, et al. · Blood
Combining Melphalan or Thiotepa with an Intensive Conditioning Regimen Significantly Reduces Relapse Rates in Minimal Residual Disease-Positive (MRD+) Pediatric Acute Myeloid Leukemia Patients Post Haploidentical Hematopoietic Stem Cell Transplantation
2024 · Huili Zhu, Zhijie Wei, et al. · Blood
P1170: Car-t Therapy Is Effective and Safe in Treating Relapsed/refractory Lymphoma With Malignant Serous Cavity Effusion
2023 · Lefu Huang, Peihua Lu · HemaSphere
Figure S3 from Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
2023 · Min-Bin Chen, Yuan-Yuan Liu, et al.
PDF
Figure S1 from Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
2023 · Min-Bin Chen, Yuan-Yuan Liu, et al.
Figure S2 from Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
2023 · Min-Bin Chen, Yuan-Yuan Liu, et al.
PDF
Figure S2 from Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
2023 · Min-Bin Chen, Yuan-Yuan Liu, et al.
Works count: 41
Citation count: 417
H-index: 5
I10-index: 2
Year
Topic
Type